Core Points - The company has announced a change in the continuous supervision sponsor representative due to the work change of the original representative, Feng Jiangtao [1] - The new sponsor representative, Tie Weiming, will take over the duties of continuous supervision alongside the existing representative, Zhong Jianggang [1] - The change will not affect the ongoing supervision work by Zhongyuan Securities [1] Group 1 - The company expresses gratitude to Feng Jiangtao for his contributions during the IPO and continuous supervision period [2] - Tie Weiming is an executive director in the Beijing Investment Banking Department of Zhongyuan Securities and has experience in various IPO projects [3] - The continuous supervision period will last until the obligations set by the China Securities Regulatory Commission and Shenzhen Stock Exchange are fulfilled [1]
辽宁何氏眼科医院集团股份有限公司关于更换持续督导保荐代表人的公告